Safety and Efficacy of MRI-Based Selection for Recombinant Tissue Plasminogen Activator Treatment: Responder Analysis of Outcome in the 3-Hour Time Window

Christine Sølling,Niels Hjort,Mahmoud Ashkanian,Leif Østergaard,Grethe Andersen

Safety and Efficacy of MRI-Based Selection for Recombinant Tissue Plasminogen Activator Treatment: Responder Analysis of Outcome in the 3-Hour Time Window

2009

Christine Sølling
Niels Hjort
Mahmoud Ashkanian
Leif Østergaard
Grethe Andersen

Introduction: The use of MRI may alter the target population for intravenous recombinant tissue plasminogen activator (rtPA) treatment relative to conventional CT. If selection chan

Keywords:

Cardiology
Intracerebral hemorrhage
Diabetes mellitus
Recombinant tissue plasminogen activator
Population
Surgery
Medicine
Internal medicine
acute ischemic stroke
acute management
time windows
Intensive care medicine
target population
Text mining

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations